Eric Chen, CEO of Injective, expects exchange-traded funds (ETFs) linked to INJ to be approved in the United States before 2027. Two ETF applications are currently pending: the 21Shares Injective ETF and the Canary Staked INJ ETF. These products would allow US investors to gain indirect exposure to the native token of the Injective ecosystem through traditional financial markets.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
